May 2, 2016 5:30 PM

Scientist to Acquire Cannabis Research Money From Crowdfunding

People have been using cannabis as medicine for many years. But, despite this fact, most governments still see a lot of obstacles to recognizing cannabis as a medical drug. The U.S. government criminalizes marijuana under the Commerce Clause, although some steps have been taking to prevent active pursuit of marijuana offenses in states where marijuana is legal.

The main question that remains to be answered is which patients can benefit from medical marijuana and how exactly should cannabis be used in the treatment of various diseases.Other drugs have undergone clinical trials; doctors can prescribe them based on ample evidence and valid scientific data. Available data on cannabis, on the other hand, is quite scarce. So, when the doctor is signing a medical marijuana card, they are not ready to give you the full information about the drug. That is why finding a solution to this problem is crucial to legalizing cannabis and cannabis-based products.

Dr. Thorsten Rudroff, a researcher from Colorado State University, is working on improving the life of people with multiple sclerosis. The doctor points out that about half of MS patients in use cannabis manage the symptoms like muscle spasms and pain. The available cannabis research seems to prove the fact that cannabis alleviates those symptoms, but the evidence are not strong enough, and there are a lot of things still unknown about both positive and negative effects of cannabis.

There are three most important things to study about the influence of cannabis on patients with MS.

  • Which type of cannabis more effective in reducing the symptoms—synthetic or plant-derived?
  • Should patients use one specific cannabinoid or a combination of cannabinoids?
  • In what way should patients use medical cannabis (drops, smoking or edibles) and how should the dose be determined?

The main purpose of Dr. Rudroff’s laboratory is to determine the efficiency of using cannabis in patients with MS. The main subject of his research is the influence of cannabis on the fatigue and motor function.

Dr. Rudroff’s considers Colorado to be the most suitable place for his studies. On one hand, the state has one of the highest rates of MS in the country—1 in 420 Coloradans live with the disease. On the other hand, legal marijuana makes Colorado a perfect place for large-scale research to explore the effects of cannabis.

Cannabis is still considered an illegal drug of the highest order in the United States. This is the main reason constraining cannabis research limiting grants from the government and non-profit organizations. That is why Dr. Rudroff with support from Colorado State University decided to acquire the money through crowdfunding.

Similar news
Study Review: How Can Cannabis Help With Multiple Sclerosis?
According to the U.S. National Multiple Sclerosis Society, more than 2.3 million people worldwide are afflicted with multiple sclerosis. This unpredictable, progressive disease causes damage to the brain and spinal cord, as well as affects the body’s immune system.
Sep 29, 2016 9:15 AM
Study on Medical Marijuana States: Tourists With Weed-Related Issues Visit Colorado ERs More Often Than Locals
According to the official study, from 2013 to 2014, the number of cannabis-related visits to the emergency room of the University of Colorado Hospital by tourists doubled, while the number of local patients did not change.
Apr 14, 2016 9:40 AM
Cannabis Facts: Marijuana and Driving
The recreational and medical usage of marijuana has already been legalized in more than 20 states, including Colorado and Washington. However, the situation is not as good as we expected.
Apr 6, 2016 5:50 PM